生物可吸收聚合物血管支架：一个警示故事。 - Suppr

Suppr

超能文献

Bioresorbable polymeric vascular scaffolds: a cautionary tale.

作者信息

Ormiston John A, De Vroey Frederic, Serruys Patrick W, Webster Mark W I

机构信息

Cardiology Department, Auckland City Hospital, Auckland, New Zealand.

出版信息

Circ Cardiovasc Interv. 2011 Oct 1;4(5):535-8. doi: 10.1161/CIRCINTERVENTIONS.111.963710.

DOI:10.1161/CIRCINTERVENTIONS.111.963710

PMID:22010192

Abstract

摘要

相似文献

Bioresorbable polymeric vascular scaffolds: a cautionary tale.生物可吸收聚合物血管支架：一个警示故事。

Circ Cardiovasc Interv. 2011 Oct 1;4(5):535-8. doi: 10.1161/CIRCINTERVENTIONS.111.963710.

Optical coherence tomography imaging of everolimus-eluting bioresorbable vascular scaffold implanted into coronary vein graft at 3-month follow-up.雷帕霉素洗脱生物可吸收血管支架植入冠状动脉静脉桥3个月随访的光学相干断层扫描成像

Eur Heart J. 2014 Sep 1;35(33):2207. doi: 10.1093/eurheartj/ehu140. Epub 2014 Apr 10.

Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.第二代生物可吸收依维莫司药物洗脱血管支架治疗冠状动脉原发狭窄的临床和影像学 6 个月随访结果。

Circulation. 2010 Nov 30;122(22):2301-12. doi: 10.1161/CIRCULATIONAHA.110.970772. Epub 2010 Nov 15.

Calcified in-stent restenosis: a rare cause of dilation failure requiring rotational atherectomy.支架内钙化再狭窄：扩张失败的罕见原因，需行旋磨术治疗。

Circ Cardiovasc Interv. 2012 Feb 1;5(1):e1-2. doi: 10.1161/CIRCINTERVENTIONS.111.966606.

First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.第二代可吸收依维莫司洗脱生物可吸收血管支架的 6 个月和 2 年的首次系列评估：多模态影像学研究。

Circ Cardiovasc Interv. 2012 Oct;5(5):620-32. doi: 10.1161/CIRCINTERVENTIONS.112.971549. Epub 2012 Oct 9.

Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.经全吸收聚合物雷帕霉素洗脱支架冠状动脉植入治疗初发冠状动脉疾病患者的 5 年临床和功能多层螺旋 CT 血管造影结果：ABSORB 队列 A 试验。

JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017.

A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.光学相干断层成像术对第一代和第二代依维莫司洗脱生物可吸收血管支架性能的比较评估。

Eur Heart J. 2011 Feb;32(3):294-304. doi: 10.1093/eurheartj/ehq458. Epub 2010 Dec 1.

Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果：ABSORB 队列 B 试验的光学相干断层成像评估（生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价）。

JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.

Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.紫杉醇洗脱球囊后扩张与依维莫司洗脱支架治疗裸金属支架：使用光学相干断层成像术在 6 个月随访时的前瞻性随机研究。

Circ Cardiovasc Interv. 2014 Dec;7(6):760-7. doi: 10.1161/CIRCINTERVENTIONS.113.001146. Epub 2014 Nov 4.

Side branch occlusion after bioresorbable vascular scaffold implantation: lessons from optimal coherence tomography.生物可吸收血管支架植入术后分支血管闭塞：光学相干断层扫描的经验教训

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):116-8. doi: 10.1016/j.jcin.2014.07.029.

引用本文的文献

Development of a polycaprolactone/poly(-dioxanone) bioresorbable stent with mechanically self-reinforced structure for congenital heart disease treatment.用于先天性心脏病治疗的具有机械自增强结构的聚己内酯/聚（-二氧杂环己酮）生物可吸收支架的研发。

Bioact Mater. 2021 Mar 1;6(9):2969-2982. doi: 10.1016/j.bioactmat.2021.02.017. eCollection 2021 Sep.

Endothelial Dysfunction and Coronary Vasoreactivity - A Review of the History, Physiology, Diagnostic Techniques, and Clinical Relevance.内皮功能障碍与冠状动脉血管反应性——历史、生理学、诊断技术及临床相关性综述。

Curr Cardiol Rev. 2021;17(1):85-100. doi: 10.2174/1573403X16666200618161942.

Radiopaque Fully Degradable Nanocomposites for Coronary Stents.用于冠状动脉支架的放射显影完全可降解纳米复合材料。

Sci Rep. 2018 Nov 27;8(1):17409. doi: 10.1038/s41598-018-35663-2.

New generation bioresorbable scaffold technologies: an update on novel devices and clinical results.新一代生物可吸收支架技术：新型器械与临床结果的最新进展

J Thorac Dis. 2017 Aug;9(Suppl 9):S979-S985. doi: 10.21037/jtd.2017.07.104.

Mechanical behavior of polymer-based . metallic-based bioresorbable stents.基于聚合物和金属的生物可吸收支架的力学行为

J Thorac Dis. 2017 Aug;9(Suppl 9):S923-S934. doi: 10.21037/jtd.2017.06.30.

The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment.球囊扩张持续时间会影响生物可吸收血管支架置入术后冠状动脉节段的管腔直径。

BMC Cardiovasc Disord. 2015 Dec 11;15:169. doi: 10.1186/s12872-015-0163-5.

Neoatherosclerosis: Coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosis.新型动脉粥样硬化：冠状动脉支架可封闭动脉粥样硬化病变，但却引发了一个新的动脉粥样硬化问题。

World J Cardiol. 2015 Nov 26;7(11):776-83. doi: 10.4330/wjc.v7.i11.776.

Degree of bioresorbable vascular scaffold expansion modulates loss of essential function.生物可吸收血管支架的扩张程度调节基本功能丧失。

Acta Biomater. 2015 Oct;26:195-204. doi: 10.1016/j.actbio.2015.08.009. Epub 2015 Aug 12.

Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.急性心肌梗死急性期植入依维莫司洗脱生物可吸收支架的新生内膜覆盖情况及晚期贴壁情况：来自PRAGUE-19研究的光学相干断层扫描数据

Heart Vessels. 2016 Jun;31(6):841-5. doi: 10.1007/s00380-015-0679-8. Epub 2015 Apr 21.

Bioresorbable scaffolds for percutaneous coronary interventions.用于经皮冠状动脉介入治疗的生物可吸收支架

Glob Cardiol Sci Pract. 2014 Dec 31;2014(4):409-27. doi: 10.5339/gcsp.2014.55. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验